Cargando…
Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT
In this study we present the porous silica-based material that can be used for in situ drug delivery, offering effective supply of active compounds regardless its water solubility. To demonstrate usability of this new material, three silica-based materials with different pore size distribution as a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947284/ https://www.ncbi.nlm.nih.gov/pubmed/31818025 http://dx.doi.org/10.3390/ma12244110 |
_version_ | 1783485514775527424 |
---|---|
author | Wawrzyńska, Magdalena Duda, Maciej Hołowacz, Iwona Kaczorowska, Aleksandra Ulatowska-Jarża, Agnieszka Buzalewicz, Igor Kałas, Wojciech Wysokińska, Edyta Biały, Dariusz Podbielska, Halina Kopaczyńska, Marta |
author_facet | Wawrzyńska, Magdalena Duda, Maciej Hołowacz, Iwona Kaczorowska, Aleksandra Ulatowska-Jarża, Agnieszka Buzalewicz, Igor Kałas, Wojciech Wysokińska, Edyta Biały, Dariusz Podbielska, Halina Kopaczyńska, Marta |
author_sort | Wawrzyńska, Magdalena |
collection | PubMed |
description | In this study we present the porous silica-based material that can be used for in situ drug delivery, offering effective supply of active compounds regardless its water solubility. To demonstrate usability of this new material, three silica-based materials with different pore size distribution as a matrix for doping with Photolon (Ph) and Protoporphyrin IX (PPIX) photosensitizers, were prepared. These matrices can be used for coating cardiovascular stents used for treatment of the coronary artery disease and enable intravascular photodynamic therapy (PDT), which can modulate the vascular response to injury caused by stent implantation—procedure that should be thought as an alternative for drug eluting stent. The FTIR spectroscopic analysis confirmed that all studied matrices have been successfully functionalized with the target photosensitizers. Atomic force microscopy revealed that resulting photoactive matrices were very smooth, which can limit the implantation damage and reduce the risk of restenosis. No viability loss of human peripheral blood lymphocytes and no erythrocyte hemolysis upon prolonged incubations on matrices indicated good biocompatibility of designed materials. The suitability of photoactive surfaces for PDT was tested in two cell lines relevant to stent implantation: vascular endothelial cells (HUVECs) and vascular smooth muscle cells (VSMC). It was demonstrated that 2 h incubation on the silica matrices was sufficient for uptake of the encapsulated photosensitizers. Moreover, the amount of the absorbed photosensitizer was sufficient for induction of a phototoxic reaction as shown by a rise of the reactive oxygen species in photosensitized VSMC. On the other hand, limited reactive oxygen species (ROS) induction in HUVECs in our experimental set up suggests that the proposed method of PDT may be less harmful for the endothelial cells and may decrease a risk of the restenosis. Presented data clearly demonstrate that porous silica-based matrices are capable of in situ delivery of photosensitizer for PDT of VSMC. |
format | Online Article Text |
id | pubmed-6947284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69472842020-01-13 Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT Wawrzyńska, Magdalena Duda, Maciej Hołowacz, Iwona Kaczorowska, Aleksandra Ulatowska-Jarża, Agnieszka Buzalewicz, Igor Kałas, Wojciech Wysokińska, Edyta Biały, Dariusz Podbielska, Halina Kopaczyńska, Marta Materials (Basel) Article In this study we present the porous silica-based material that can be used for in situ drug delivery, offering effective supply of active compounds regardless its water solubility. To demonstrate usability of this new material, three silica-based materials with different pore size distribution as a matrix for doping with Photolon (Ph) and Protoporphyrin IX (PPIX) photosensitizers, were prepared. These matrices can be used for coating cardiovascular stents used for treatment of the coronary artery disease and enable intravascular photodynamic therapy (PDT), which can modulate the vascular response to injury caused by stent implantation—procedure that should be thought as an alternative for drug eluting stent. The FTIR spectroscopic analysis confirmed that all studied matrices have been successfully functionalized with the target photosensitizers. Atomic force microscopy revealed that resulting photoactive matrices were very smooth, which can limit the implantation damage and reduce the risk of restenosis. No viability loss of human peripheral blood lymphocytes and no erythrocyte hemolysis upon prolonged incubations on matrices indicated good biocompatibility of designed materials. The suitability of photoactive surfaces for PDT was tested in two cell lines relevant to stent implantation: vascular endothelial cells (HUVECs) and vascular smooth muscle cells (VSMC). It was demonstrated that 2 h incubation on the silica matrices was sufficient for uptake of the encapsulated photosensitizers. Moreover, the amount of the absorbed photosensitizer was sufficient for induction of a phototoxic reaction as shown by a rise of the reactive oxygen species in photosensitized VSMC. On the other hand, limited reactive oxygen species (ROS) induction in HUVECs in our experimental set up suggests that the proposed method of PDT may be less harmful for the endothelial cells and may decrease a risk of the restenosis. Presented data clearly demonstrate that porous silica-based matrices are capable of in situ delivery of photosensitizer for PDT of VSMC. MDPI 2019-12-09 /pmc/articles/PMC6947284/ /pubmed/31818025 http://dx.doi.org/10.3390/ma12244110 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wawrzyńska, Magdalena Duda, Maciej Hołowacz, Iwona Kaczorowska, Aleksandra Ulatowska-Jarża, Agnieszka Buzalewicz, Igor Kałas, Wojciech Wysokińska, Edyta Biały, Dariusz Podbielska, Halina Kopaczyńska, Marta Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT |
title | Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT |
title_full | Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT |
title_fullStr | Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT |
title_full_unstemmed | Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT |
title_short | Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT |
title_sort | photoactive pore matrix for in situ delivery of a photosensitizer in vascular smooth muscle cells selective pdt |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947284/ https://www.ncbi.nlm.nih.gov/pubmed/31818025 http://dx.doi.org/10.3390/ma12244110 |
work_keys_str_mv | AT wawrzynskamagdalena photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT dudamaciej photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT hołowacziwona photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT kaczorowskaaleksandra photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT ulatowskajarzaagnieszka photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT buzalewiczigor photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT kałaswojciech photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT wysokinskaedyta photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT białydariusz photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT podbielskahalina photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt AT kopaczynskamarta photoactiveporematrixforinsitudeliveryofaphotosensitizerinvascularsmoothmusclecellsselectivepdt |